These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9784135)

  • 21. Microsomal transfer protein inhibition in humans.
    Cuchel M; Rader DJ
    Curr Opin Lipidol; 2013 Jun; 24(3):246-50. PubMed ID: 23594709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Action of ciprofibrate in type IIb hyperlipoproteinemia: modulation of the atherogenic lipoprotein phenotype and stimulation of high-density lipoprotein-mediated cellular cholesterol efflux.
    Guerin M; Le Goff W; Frisdal E; Schneider S; Milosavljevic D; Bruckert E; Chapman MJ
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3738-46. PubMed ID: 12915663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Watanabe heritable hyperlipidemic rabbit. Animal model for familial hypercholesterolemia.
    Havel RJ; Yamada N; Shames DM
    Arteriosclerosis; 1989; 9(1 Suppl):I33-8. PubMed ID: 2643428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative study on serum lipids and atherosclerotic plaque formation in diet-induced and familial hypercholesterolemia in rabbits, and the effect of partial ileal bypass.
    van Niekerk JL; Demacker PN; Hendriks T; de Boer HH
    Artery; 1985; 12(4):263-76. PubMed ID: 4074136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased secretion of ApoB follows inhibition of ApoB-MTP binding by a novel antagonist.
    Bakillah A; Nayak N; Saxena U; Medford RM; Hussain MM
    Biochemistry; 2000 Apr; 39(16):4892-9. PubMed ID: 10769147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intermediate density lipoprotein cholesterol as the best lipoprotein predictor of atherosclerosis severity in the Watanabe Heritable Hyperlipidemic rabbit.
    Nordestgaard BG; Agerholm-Larsen B; Mortensen A; Fischer Hansen B; Fischer Hansen J; Ibsen P; Kjeldsen K
    Atherosclerosis; 1997 Jul; 132(1):119-22. PubMed ID: 9247367
    [No Abstract]   [Full Text] [Related]  

  • 27. Natural history of atherosclerosis and hyperlipidemia in heterozygous WHHL (WHHL-Hh) rabbits. I. The effects of aging and gender on plasma lipids and lipoproteins.
    Esper E; Chan EK; Buchwald H
    J Lab Clin Med; 1993 Jan; 121(1):97-102. PubMed ID: 8426086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, ameliorates lipid metabolism and attenuates atherosclerosis in hyperlipidemic animal models.
    Mera Y; Kawai T; Ogawa N; Odani N; Sasase T; Miyajima K; Ohta T; Kakutani M
    J Pharmacol Sci; 2015 Nov; 129(3):169-76. PubMed ID: 26598005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased clearance of plasma cholesterol after injection of apolipoprotein E into Watanabe heritable hyperlipidemic rabbits.
    Yamada N; Shimano H; Mokuno H; Ishibashi S; Gotohda T; Kawakami M; Watanabe Y; Akanuma Y; Murase T; Takaku F
    Proc Natl Acad Sci U S A; 1989 Jan; 86(2):665-9. PubMed ID: 2911597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stimulation of cholesteryl ester synthesis in mouse peritoneal macrophages by cholesterol-rich very low density lipoproteins from the Watanabe heritable hyperlipidemic rabbit, an animal model of familial hypercholesterolemia.
    Kita T; Yokode M; Watanabe Y; Narumiya S; Kawai C
    J Clin Invest; 1986 May; 77(5):1460-5. PubMed ID: 3700648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological characterization of diethyl-2-({3-dimethylcarbamoyl-4-[(4'-trifluoromethylbiphenyl-2-carbonyl)amino]phenyl}acetyloxymethyl)-2-phenylmalonate (JTT-130), an intestine-specific inhibitor of microsomal triglyceride transfer protein.
    Mera Y; Odani N; Kawai T; Hata T; Suzuki M; Hagiwara A; Katsushima T; Kakutani M
    J Pharmacol Exp Ther; 2011 Feb; 336(2):321-7. PubMed ID: 20974698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microsomal transfer protein inhibitors, new approach for treatment of familial hypercholesterolemia, review of the literature, original findings, and clinical significance.
    Kolovou G; Vasiliadis I; Gontoras N; Kolovou V; Hatzigeorgiou G
    Cardiovasc Ther; 2015 Apr; 33(2):71-8. PubMed ID: 25604780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contemporary aspects of the biology and therapeutic regulation of the microsomal triglyceride transfer protein.
    Hooper AJ; Burnett JR; Watts GF
    Circ Res; 2015 Jan; 116(1):193-205. PubMed ID: 25552696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of FR145237, a novel ACAT inhibitor, on atherogenesis in cholesterol-fed and WHHL rabbits. Evidence for a direct effect on the arterial wall.
    Matsuo M; Ito F; Konto A; Aketa M; Tomoi M; Shimomura K
    Biochim Biophys Acta; 1995 Dec; 1259(3):254-60. PubMed ID: 8541332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypertriglyceridemia in Watanabe heritable hyperlipidemic rabbits was associated with increased production and reduced catabolism of very-low-density lipoproteins.
    Zhang C; Jin Y; Liu T; Liu F; Ito T
    Pathobiology; 2009; 76(6):315-21. PubMed ID: 19955843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reproductive performance and changes in blood lipids in breeding females and in growing Watanabe heritable hyperlipidaemic and New Zealand White rabbits.
    Mortensen A; Frandsen H
    Lab Anim; 1996 Jul; 30(3):252-9. PubMed ID: 8843050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microsomal triglyceride transfer protein inhibitors: discovery and synthesis of alkyl phosphonates as potent MTP inhibitors and cholesterol lowering agents.
    Magnin DR; Biller SA; Wetterau J; Robl JA; Dickson JK; Taunk P; Harrity TW; Lawrence RM; Sun CQ; Wang T; Logan J; Fryszman O; Connolly F; Jolibois K; Kunselman L
    Bioorg Med Chem Lett; 2003 Apr; 13(7):1337-40. PubMed ID: 12657277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microsomal triglyceride transfer protein inhibition: a novel treatment for lowering plasma cholesterol.
    Das G; Rees A
    Curr Opin Lipidol; 2014 Dec; 25(6):471-3. PubMed ID: 25370457
    [No Abstract]   [Full Text] [Related]  

  • 39. Lipids and lipoprotein changes after heart and liver transplantation in a patient with homozygous familial hypercholesterolemia.
    Valdivielso P; Escolar JL; Cuervas-Mons V; Pulpón LA; Chaparro MA; González-Santos P
    Ann Intern Med; 1988 Feb; 108(2):204-6. PubMed ID: 3277507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of CS-514, a new inhibitor of HMG CoA reductase, on plasma lipids, lipoproteins and apoproteins in patients with primary hypercholesterolemia.
    Kazumi T; Yoshino G; Kasama T; Iwatani I; Iwai M; Morita S; Baba S
    Horm Metab Res; 1986 Sep; 18(9):654-5. PubMed ID: 3096862
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.